Latest news with #Asher
Economic Times
12 hours ago
- Business
- Economic Times
JM Financial retains Buy on Deepak Nitrite, keeps target price unchanged at Rs 2,305
Deepak Nitrite's key products/revenue segments include Fine Chemicals, Export Incentives, Scrap, Sale of services and Other Operating Revenue for the year ending 31-Mar-2024. Financials For the quarter ended 31-03-2025, the company has reported a Consolidated Total Income of Rs 2202.48 crore, up 14.45% from last quarter Total Income of Rs 1924.39 crore and up 2.66% from last year same quarter Total Income of Rs 2145.34 crore. The company has reported net profit after tax of Rs 202.50 crore in the latest quarter. The company's top management includes C Mehta, Asher, Sheth, Lalbhai, Shah, Samudra, Satarkar, Mehta, C Mehta, Upadhyay, D Mehta, Choksi. Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2025, the company has a total of 14 Crore shares outstanding. Live Events Investment Rationale Deepak Nitrite's 4QFY25 earnings print was significantly better than our and consensus expectations primarily on account of government incentives. The company will continue to receive these incentives on the existing phenol complex as well the upcoming polycarbonate complex. On the operational front, advanced intermediates (AI) performance showed sequential improvement. Going ahead, volume normalisation in the AI segment is likely from 2HFY26. Moreover, commissioning of backward integration capex in the AI segment (including nitric acid, photo chlorination) should help lift AI segment margins from 2QFY26, according to JM FInancial. On the phenolics side, benefits of MIBK/MIBC and acetophenone commissioning are likely to flow through from 3QFY26. Besides that, we are also factoring in some improvement in phenol-acetone spreads. There has been a delay in the commissioning of various projects. Hence, on overall basis, the brokerage's FY26-27 EPS estimates are revised downwards by ~1%. Since Deepak Nitrite has the potential to more than quadruple its EBITDA over thenext 5 years, JM Financial maintains their BUY rating on the name with an unchanged Mar?26 target price of Rs 2,305/share (based on 30x Mar?27E EPS). Promoter/FII Holdings Promoters held 49.28 per cent stake in the company as of 31-Mar-2025, while FIIs owned 6.64 per cent, DIIs 23.22 per cent. (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel JM Financial has maintained Buy call on Deepak Nitrite with a target price of Rs 2,305 (unchanged). The current market price of Deepak Nitrite is Rs 2027.75. The time period given by the analyst is a year when Deepak Nitrite price can reach the defined target. Deepak Nitrite, incorporated in 1970, is a Mid Cap company with a market cap of Rs 27650.96 crore, operating in Chemicals Nitrite's key products/revenue segments include Fine Chemicals, Export Incentives, Scrap, Sale of services and Other Operating Revenue for the year ending the quarter ended 31-03-2025, the company has reported a Consolidated Total Income of Rs 2202.48 crore, up 14.45% from last quarter Total Income of Rs 1924.39 crore and up 2.66% from last year same quarter Total Income of Rs 2145.34 crore. The company has reported net profit after tax of Rs 202.50 crore in the latest company's top management includes C Mehta, Asher, Sheth, Lalbhai, Shah, Samudra, Satarkar, Mehta, C Mehta, Upadhyay, D Mehta, Choksi. Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2025, the company has a total of 14 Crore shares Nitrite's 4QFY25 earnings print was significantly better than our and consensus expectations primarily on account of government incentives. The company will continue to receive these incentives on the existing phenol complex as well the upcoming polycarbonate complex. On the operational front, advanced intermediates (AI) performance showed sequential improvement. Going ahead, volume normalisation in the AI segment is likely from 2HFY26. Moreover, commissioning of backward integration capex in the AI segment (including nitric acid, photo chlorination) should help lift AI segment margins from 2QFY26, according to JM FInancial. On the phenolics side, benefits of MIBK/MIBC and acetophenone commissioning are likely to flow through from 3QFY26. Besides that, we are also factoring in some improvement in phenol-acetone spreads. There has been a delay in the commissioning of various projects. Hence, on overall basis, the brokerage's FY26-27 EPS estimates are revised downwards by ~1%. Since Deepak Nitrite has the potential to more than quadruple its EBITDA over thenext 5 years, JM Financial maintains their BUY rating on the name with an unchanged Mar?26 target price of Rs 2,305/share (based on 30x Mar?27E EPS).Promoters held 49.28 per cent stake in the company as of 31-Mar-2025, while FIIs owned 6.64 per cent, DIIs 23.22 per cent. (Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
Time of India
12 hours ago
- Business
- Time of India
JM Financial retains Buy on Deepak Nitrite, keeps target price unchanged at Rs 2,305
Deepak Nitrite's key products/revenue segments include Fine Chemicals, Export Incentives, Scrap, Sale of services and Other Operating Revenue for the year ending 31-Mar-2024. Financials For the quarter ended 31-03-2025, the company has reported a Consolidated Total Income of Rs 2202.48 crore, up 14.45% from last quarter Total Income of Rs 1924.39 crore and up 2.66% from last year same quarter Total Income of Rs 2145.34 crore. The company has reported net profit after tax of Rs 202.50 crore in the latest quarter. The company's top management includes C Mehta, Asher, Sheth, Lalbhai, Shah, Samudra, Satarkar, Mehta, C Mehta, Upadhyay, D Mehta, Choksi. Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2025, the company has a total of 14 Crore shares outstanding. Live Events Investment Rationale Deepak Nitrite's 4QFY25 earnings print was significantly better than our and consensus expectations primarily on account of government incentives. The company will continue to receive these incentives on the existing phenol complex as well the upcoming polycarbonate complex. On the operational front, advanced intermediates (AI) performance showed sequential improvement. Going ahead, volume normalisation in the AI segment is likely from 2HFY26. Moreover, commissioning of backward integration capex in the AI segment (including nitric acid, photo chlorination) should help lift AI segment margins from 2QFY26, according to JM FInancial. On the phenolics side, benefits of MIBK/MIBC and acetophenone commissioning are likely to flow through from 3QFY26. Besides that, we are also factoring in some improvement in phenol-acetone spreads. There has been a delay in the commissioning of various projects. Hence, on overall basis, the brokerage's FY26-27 EPS estimates are revised downwards by ~1%. Since Deepak Nitrite has the potential to more than quadruple its EBITDA over thenext 5 years, JM Financial maintains their BUY rating on the name with an unchanged Mar?26 target price of Rs 2,305/share (based on 30x Mar?27E EPS). Promoter/FII Holdings Promoters held 49.28 per cent stake in the company as of 31-Mar-2025, while FIIs owned 6.64 per cent, DIIs 23.22 per cent. (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel JM Financial has maintained Buy call on Deepak Nitrite with a target price of Rs 2,305 (unchanged). The current market price of Deepak Nitrite is Rs 2027.75. The time period given by the analyst is a year when Deepak Nitrite price can reach the defined target. Deepak Nitrite, incorporated in 1970, is a Mid Cap company with a market cap of Rs 27650.96 crore, operating in Chemicals Nitrite's key products/revenue segments include Fine Chemicals, Export Incentives, Scrap, Sale of services and Other Operating Revenue for the year ending the quarter ended 31-03-2025, the company has reported a Consolidated Total Income of Rs 2202.48 crore, up 14.45% from last quarter Total Income of Rs 1924.39 crore and up 2.66% from last year same quarter Total Income of Rs 2145.34 crore. The company has reported net profit after tax of Rs 202.50 crore in the latest company's top management includes C Mehta, Asher, Sheth, Lalbhai, Shah, Samudra, Satarkar, Mehta, C Mehta, Upadhyay, D Mehta, Choksi. Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2025, the company has a total of 14 Crore shares Nitrite's 4QFY25 earnings print was significantly better than our and consensus expectations primarily on account of government incentives. The company will continue to receive these incentives on the existing phenol complex as well the upcoming polycarbonate complex. On the operational front, advanced intermediates (AI) performance showed sequential improvement. Going ahead, volume normalisation in the AI segment is likely from 2HFY26. Moreover, commissioning of backward integration capex in the AI segment (including nitric acid, photo chlorination) should help lift AI segment margins from 2QFY26, according to JM FInancial. On the phenolics side, benefits of MIBK/MIBC and acetophenone commissioning are likely to flow through from 3QFY26. Besides that, we are also factoring in some improvement in phenol-acetone spreads. There has been a delay in the commissioning of various projects. Hence, on overall basis, the brokerage's FY26-27 EPS estimates are revised downwards by ~1%. Since Deepak Nitrite has the potential to more than quadruple its EBITDA over thenext 5 years, JM Financial maintains their BUY rating on the name with an unchanged Mar?26 target price of Rs 2,305/share (based on 30x Mar?27E EPS).Promoters held 49.28 per cent stake in the company as of 31-Mar-2025, while FIIs owned 6.64 per cent, DIIs 23.22 per cent. (Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
Yahoo
15 hours ago
- General
- Yahoo
Brigid's Path provides care for families impacted by substance abuse
DAYTON, Ohio (WDTN) — One facility is battling the opioid crisis by helping mothers and babies recover from addictive substances. Brigid's Path has saved nearly 300 babies since 2017, by providing 24/7 medical care to children exposed to addictive substances. The president of the CDC Foundation visited the facility to spread their message and encourage the community to support their mission. 'Brigid's Path gives grace, and they don't judge you,' said Ashley Wells, previous Brigid's Path patient. 'And this is a place where they would just help anybody.' Wells is just one of the nearly 300 mothers that Brigid's Path has helped since 2017. She says the facility has been life changing for her and her son, Asher. 'Once I had Asher, we were in the NICU for about two and a half weeks, and then we came here,' said Wells. 'And since then, our lives have just changed.' Brigid's Path helps babies and families affected by substance abuse in the southwestern Ohio region — one of the hardest hit areas by the opioid crisis. On Monday, President and CEO of the CDC Foundation — and Dayton native — Dr. Judy Monroe visited Brigid's Path, showing support for the facility and encouraging more places like it nationwide. 'We want to continue the success, there's an amazing staff here. I mean, the passion I've seen today is just amazing,' said Dr. Judy Monroe, CDC Foundation president, CEO. 'With an eye toward replicating nationally, there are only a few centers like this across the nation.' The facility is only one of five in the U.S. of its kind, providing care to families struggling with addition and making it a point to not only support holistically, but also to lower costs for hospital systems by thousands of dollars. President and founder of Brigid's Path, Jill Kingston, says they are excited at the push for national expansion, but right now, they are pushing for community gap funding, as they await Medicaid reimbursement. 'Seeing the national support that we're getting has been a huge blessing, working with the state of Ohio to put Medicaid in place,' said Jill Kingston, Brigid's Path founding president. 'But it's not in place yet, so we have this gap in funding that we're trying to fill in, asking for the community's help to get that done.' Brigid's Path reports 85 percent of newborns helped at the facility are discharged into family care, 70 percent of which would have otherwise had to be placed in foster care, ultimately helping families like Wells' stay and grow together. 'And it's important for people to keep funding this place so other parents and other moms and other babies can get the help and services they need as well,' said Wells. Brigid's Path is asking for community support — if you would like to donate, visit their website. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
5 days ago
- General
- Yahoo
2 arrested, ‘large quantity' of drugs seized in Laurel County investigation
LONDON, Ky. (FOX 56) — A Louisville man and a Manchester woman were arrested on Wednesday night after allegedly being found with a large amount of drugs during a London traffic stop. Court records show that just before 6:45 p.m. on May 28, detectives with the Laurel County Sheriff's Drug Interdiction Unit helped with a traffic stop on East 4th Street. The sheriff's office posted on Facebook that while searching a blue Dodge Charger driven by 44-year-old Johnny Asher of Louisville, authorities allegedly found 'a large quantity of suspected methamphetamine, marijuana, and a smoking pipe.' Popular Winchester festival announces shuttle service: Where to be during second weekend of June 2 arrested, 'large quantity' of drugs seized in Laurel County investigation Morehead man 'blacked out' after revealing $225K lottery win Asher was charged with first-degree conspiracy to traffic in methamphetamine, first offense, and possession of drug paraphernalia. An arrest citation shows that 49-year-old Roberta Ann Benge of Manchester was in the passenger seat of the Charger during the investigation. Benge allegedly told authorities she had a small plastic bag of marijuana under her clothes. She was arrested and charged with first-degree trafficking in two grams or more of methamphetamine, first offense—possession of drug paraphernalia, and possession of marijuana. The Laurel County drug investigation remains ongoing. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
India Gazette
6 days ago
- Business
- India Gazette
Customers shifting to 18-carat jewellery from 22-carat as gold rates rise: Malabar Gold
New Delhi [India], May 28 (ANI): There has been a shift in preference by gold jewellery buyers with the rising prices of the yellow metal. Talking to reporters on Wednesday in the national capital, O Asher, Managing Director of Indian operations for Malabar Gold and Diamonds, said, rising gold prices are driving customers to shift from 22-carat to 18-carat jewelry. While the overall value of gold jewellery sales has increased, the per-customer volume has declined, he said. 'We are creating lighter-weight jewelry while maintaining the same designs to keep pieces within our customers' budgets,' Asher explained. 'If someone has a budget of one lakh rupees, they cannot increase it, so we've adapted our strategy. By keeping designs identical but reducing weight slightly, we ensure customers' aspirations aren't compromised,' Asher added. 'In some regions, we have observed customers transitioning from 22-carat to 18-carat jewelry.' Publicly available data showed that international gold prices rose at an unprecedented pace in 2025, soaring over 25 per cent. Over the past year, they have risen about 45 per cent. Analysts say that buyers are staying away from purchasing gold jewellery or investing in the metal, owing to an unexpected rise in prices. Gold prices, both in India and worldwide, are trading at their all-time highs or nearabout, due to its safe-haven appeal amidst ongoing trade uncertainties. The uncertainties surrounding Trump's reciprocal tariffs plan and counter-tariffs also came as a shot in the arm to international gold prices. Coming back to Asher, asked about the Federation of Indian Export Organisations' (FIEO) projections of USD 1 trillion in exports in 2025-26, he emphasized the target was reachable. 'Our focus is to manufacture in India and market to the world. We operate in 13 countries, and if businesses work in line with our Prime Minister's vision, I am 100 percent confident we will achieve the USD 1 trillion export target.' Today, MP Ahammed, Chairman of Malabar Group, has provided insights on market conditions. 'Gold prices remain unpredictable, with no clear indication of future direction. However, recent surges stem from US President Donald Trump's tariff policies and ongoing geopolitical tensions. Rising jewelry prices actually boost consumer confidence, as we've witnessed consistent price appreciation over the past 25-30 years,' Ahammed said. Gold has become a preferred global reserve asset, with governments and central banks worldwide increasing their holdings. The share of gold maintained by the Reserve Bank of India (RBI) in its foreign exchange reserves has almost doubled since 2021. According to a report on Management of Foreign Exchange Reserves by the Indian central bank, the gold share in forex kitty, in dollar terms, rose from 5.87 per cent in March 2021 to 11.70 per cent in March 2025. In September 2024, the gold's share was at 9.32 per cent. Historically, gold, as an asset, is considered to be a haven as it typically manages to retain or appreciate its underlying value in times of turbulence. (ANI)
